- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03288311
Protocolized Post-Extubation Respiratory Support Study (PROPER)
December 27, 2023 updated by: Jonathan Casey, Vanderbilt University Medical Center
Protocolized Post-Extubation Respiratory Support (PROPER) Study
Invasive mechanical ventilation is common in the medical intensive care unit, and the period of time following extubation remains high risk as 11 to 15% of patients require reintubation after their first extubation.
Reintubation is associated with increased rates of nosocomial infection and is an independent predictor of mortality.
Non-invasive ventilation and high flow nasal cannula are the only therapies that have been shown to reduce the rate of reintubation.
Recent clinical trials suggest that all patients might benefit from some form of post-extubation respiratory support, but use of these therapies in usual care remains low.
PROPER is a cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol to provide post-extubation respiratory support to all patients, compared to usual care.
The trial will enroll patients undergoing extubation in the Medical ICU at Vanderbilt from October 2017 until March 2019.
The primary outcome will be reintubation within 96 hours.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
PROPER is a prospective, pragmatic, cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol for post-extubation respiratory support to usual care.
The primary outcome will be reintubation by 96 hours.
All adults (age 18 or older) who receive at least 12 hours of mechanical ventilation and are extubated in the Vanderbilt Medical ICU will be enrolled in the trial.
The ICU will be divided into 2 clusters, based on the geographic areas covered by the two respiratory therapist dedicated to that ICU.
The study will occur in three month blocks.
One cluster will be randomized to receive protocolized post-extubation respiratory support (as prescribed by a protocol and delivered by a respiratory therapist), while the other cluster receives usual care, which can include post-extubation respiratory support when requested by the clinical team.
At the end of three months, the clusters will cross-over, such that each cluster will spend half of the study receiving protocolized post-extubation respiratory and half of the study receiving usual care.
It is anticipated that approximately 630 patients will be enrolled from the medical ICU during the 18 month study period.
Study Type
Interventional
Enrollment (Actual)
751
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37212
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient is located in a participating unit
- Patient undergoing extubation from mechanical ventilation
- Patient has been receiving mechanical ventilation for at least 12 hours
- Age ≥ 18 years old
Exclusion Criteria:
- Patient is receiving ventilation via a tracheostomy
- Patient is being extubated to comfort measures or has "Do Not Reintubate" order in place at the time of extubation
- Patient has required reintubation after a prior attempt at extubation during this hospitalization
- Unplanned or self-extubation, where immediate reintubation is deemed necessary by the clinical team
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Protocolized Post-extubation Respiratory Support
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
|
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
|
Active Comparator: Usual Care
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
|
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reintubation
Time Frame: within 96 hours of extubation
|
Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation
|
within 96 hours of extubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause In-hospital Death
Time Frame: from extubation to discharge or 28 days post-extubation
|
All cause mortality, censored at the first of hospital discharge or 28 days after extubation
|
from extubation to discharge or 28 days post-extubation
|
ICU-free Days
Time Frame: from extubation to discharge or 28 days post-extubation
|
number of days alive from final ICU transfer until study day 28
|
from extubation to discharge or 28 days post-extubation
|
Ventilator-free Days
Time Frame: from extubation to discharge or 28 days post-extubation
|
number of days alive from final invasive mechanical ventilation until study day 28
|
from extubation to discharge or 28 days post-extubation
|
Time to Reintubation
Time Frame: from extubation to discharge or 28 days post-extubation
|
Time from extubation to reintubation
|
from extubation to discharge or 28 days post-extubation
|
Number of Patients Requiring Re-intubation for Respiratory Indication
Time Frame: within 96 hours of extubation
|
Number of patients in each group with respiratory indication for reintubation.
|
within 96 hours of extubation
|
Number of Patients Requiring Reintubation for Laryngeal Edema
Time Frame: within 96 hours of extubation
|
Percentage of patients in each group with laryngeal edema as the indication for reintubation
|
within 96 hours of extubation
|
Number of Patients With Delirium
Time Frame: within 96 hours of extubation
|
As defined by Confusion Assessment Method for the ICU (CAM-ICU) score and reported by bedside nurse.
A report of "Yes" indicates the presence of delirium, which is reflected in the reported cases.
|
within 96 hours of extubation
|
Number of Patients With Agitation
Time Frame: within 96 hours of extubation
|
As defined by RAS score and reported by bedside nurse
|
within 96 hours of extubation
|
Lowest S/F Ratio
Time Frame: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
|
Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
|
between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
|
Highest Respiratory Rate
Time Frame: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
|
Highest respiratory rate
|
between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
|
Use of High Flow Nasal Cannula (HFNC) or Non-invasive Ventilation (NIV) Beyond 24 Hours Post-extubation
Time Frame: from 24 hours post extubation to 96 hours post-extubation
|
Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation
|
from 24 hours post extubation to 96 hours post-extubation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Todd W Rice, MD, MSc, Vanderbilt University Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Casey JD, Vaughan EM, Lloyd BD, Billas PA, Jackson KE, Hall EJ, Toporek AH, Buell KG, Brown RM, Richardson RK, Rooks JC, Buie RB, Wang L, Lindsell CJ, Ely EW, Self WH, Bernard GR, Rice TW, Semler MW. Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2021 Aug 1;204(3):294-302. doi: 10.1164/rccm.202009-3561OC.
- Casey JD, Vaughan ER, Lloyd BD, Bilas PA, Hall EJ, Toporek AH, Buell KG, Brown RM, Richardson RK, Rooks JC, Wang L, Lindsell CJ, Ely EW, Self WH, Bernard GR, Rice TW, Semler MW; Pragmatic Critical Care Research Group. Protocolized Post-Extubation Respiratory Support to prevent reintubation: protocol and statistical analysis plan for a clinical trial. BMJ Open. 2019 Aug 2;9(8):e030476. doi: 10.1136/bmjopen-2019-030476.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2017
Primary Completion (Actual)
March 31, 2019
Study Completion (Actual)
April 28, 2019
Study Registration Dates
First Submitted
September 15, 2017
First Submitted That Met QC Criteria
September 15, 2017
First Posted (Actual)
September 20, 2017
Study Record Updates
Last Update Posted (Actual)
December 29, 2023
Last Update Submitted That Met QC Criteria
December 27, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 170650
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
Data will be available following publication of the primary trial results
IPD Sharing Access Criteria
Data dictionary will be available upon requests.
Requests for deidentified patient-level data will be reviewed by the trial steering committee.
Sharing of deidentified data will require approval of proposed secondary analysis and a signed data use agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation Complication
-
Emory UniversityTerminatedAirway Morbidity | Intubation Complication | Anesthesia Intubation Complication | Tracheal Intubation Morbidity | Failed or Difficult Intubation, SequelaUnited States
-
University Hospital HeidelbergRecruitingIntubation | Intubation ComplicationGermany
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation Complication | Intubation, DifficultTaiwan
-
Huazhong University of Science and TechnologyCompletedIntubation Complication | Intubation; DifficultChina
-
University at BuffaloTerminatedIntubation Complication | Intubation;DifficultUnited States
-
Heinrich-Heine University, DuesseldorfCompleted
-
Spanish Network for Research in Infectious DiseasesCompletedIntubation | Intubation Complication | Intubation; Difficult or FailedSpain
-
Udayana UniversityCompletedAnesthesia | Intubation Complication | Intubation;DifficultIndonesia
-
Hospital General Universitario de ValenciaFIPSERecruitingDifficult Intubation | Anesthesia Intubation ComplicationSpain
-
University Hospital, Clermont-FerrandSociété Française d'Anesthésie-Réanimation (SFAR)Not yet recruitingEndotracheal Intubation | Intubation Complication | Intubation; Difficult or Failed
Clinical Trials on Protocolized post-extubation respiratory support
-
Christiana Care Health ServicesRecruitingBronchopulmonary Dysplasia | PrematurityUnited States
-
University Hospital, CaenNot yet recruitingExtubation Failure
-
Azienda Ospedaliero Universitaria Maggiore della...UnknownAcute Respiratory Failure | Non-invasive VentilationItaly
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationAirway Extubation | Acute Respiratory FailureUnited States
-
University Hospital, Clermont-FerrandUniversity Hospital, MontpellierCompletedRespiratory Failure | Surgery | Intubation | Anesthesia | Complication,Postoperative | ExtubationFrance
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)RecruitingExtracorporeal Membrane Oxygenation | Acute Respiratory Distress SyndromeUnited States
-
University of California, San FranciscoInnovations for Poverty Action; Marie Stopes InternationalCompletedReproductive HealthKenya
-
Karadeniz Technical UniversityCompletedPremature InfantsTurkey
-
Denver Health and Hospital AuthorityWithdrawn
-
Eskisehir Osmangazi UniversityCompleted